SGLT2 inhibitors: an evidence-based update on cardiovascular implications
I Forzano, S Wilson, A Lombardi… - Expert Opinion on …, 2023 - Taylor & Francis
ABSTRACT Introduction Sodium Glucose co-Transporter 2 (SGLT2) inhibitors (also known
as 'gliflozins') represent a cornerstone to treat diabetes mellitus. Moreover, recent …
as 'gliflozins') represent a cornerstone to treat diabetes mellitus. Moreover, recent …
Inflammation and Heart Failure: Searching for the Enemy—Reaching the Entelechy
I Paraskevaidis, D Farmakis, G Papingiotis… - Journal of …, 2023 - mdpi.com
The pivotal role of inflammation in the pathophysiology of heart-failure (HF) development
and progression has long been recognized. High blood levels of pro-inflammatory and …
and progression has long been recognized. High blood levels of pro-inflammatory and …
[HTML][HTML] Functional lipids and cardiovascular disease reduction: a concise review
Functional lipids are dietary substances that may have an impact on human health by
lowering the risk of chronic illnesses and enhancing the quality of life. Numerous functional …
lowering the risk of chronic illnesses and enhancing the quality of life. Numerous functional …
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: a comprehensive review ranging from sulphonylureas to SGLT2 inhibitors
AJ Scheen - Diabetes & Metabolism, 2022 - Elsevier
Type 2 diabetes is associated with a higher risk of cardiac arrhythmias, especially in
presence of cardiovascular disease and/or heart failure. Even if atrial fibrillation/flutter …
presence of cardiovascular disease and/or heart failure. Even if atrial fibrillation/flutter …
Effect of alpha-lipoic acid on rat ventricles and atria under LPS-induced oxidative stress
B Skibska, A Goraca, A Skibska, A Stanczak - Antioxidants, 2022 - mdpi.com
Alpha-lipoic acid (α-LA) is a disulfide compound and one of the most effective antioxidants.
Many studies have indicated positive effects of α-LA in the prevention of pathologic …
Many studies have indicated positive effects of α-LA in the prevention of pathologic …
Distress-mediated remodeling of cardiac connexin-43 in a novel cell model for arrhythmogenic heart diseases
CM Wahl, C Schmidt, M Hecker, ND Ullrich - International Journal of …, 2022 - mdpi.com
Gap junctions and their expression pattern are essential to robust function of intercellular
communication and electrical propagation in cardiomyocytes. In healthy myocytes, the main …
communication and electrical propagation in cardiomyocytes. In healthy myocytes, the main …
Hypertension and arrhythmias: a clinical overview of the pathophysiology-driven management of cardiac arrhythmias in hypertensive patients
Because of demographic aging, the prevalence of arterial hypertension (HTN) and cardiac
arrhythmias, namely atrial fibrillation (AF), is progressively increasing. Not only are these …
arrhythmias, namely atrial fibrillation (AF), is progressively increasing. Not only are these …
Severe mental illness: cardiovascular risk assessment and management
C Polcwiartek, K O'Gallagher, DJ Friedman… - European Heart …, 2024 - academic.oup.com
Patients with severe mental illness (SMI) including schizophrenia and bipolar disorder die
on average 15–20 years earlier than the general population often due to sudden death that …
on average 15–20 years earlier than the general population often due to sudden death that …
Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease
XF Li, CQ Wan, YM Mao - Frontiers in medicine, 2022 - frontiersin.org
Chronic obstructive pulmonary disease (COPD) is a disease characterized by persistent
airflow limitation, and is associated with abnormal inflammatory responses in the lungs to …
airflow limitation, and is associated with abnormal inflammatory responses in the lungs to …
Simvastatin Reduces Doxorubicin-Induced Cardiotoxicity: Effects beyond Its Antioxidant Activity
M Pecoraro, S Marzocco, R Belvedere… - International Journal of …, 2023 - mdpi.com
This study aimed to evaluate if Simvastatin can reduce, and/or prevent, Doxorubicin (Doxo)-
induced cardiotoxicity. H9c2 cells were treated with Simvastatin (10 µM) for 4 h and then …
induced cardiotoxicity. H9c2 cells were treated with Simvastatin (10 µM) for 4 h and then …